Yatırımcı.AI

TRILC vs TUPRS Comparison

Price, market cap, valuation, profitability and leverage metrics of TRILC and TUPRS side by side.

TRILCTUPRS
StockFund

If You Had Invested TRY 10,000

Metric Comparison

TRILC vs TUPRS Comparison
MetricTRILCTUPRSSector median
Last price (TL)0.78354.0012.46
Daily change−1.27%1.58%1.61%
Market capTRY 808.9MTRY 682.1BTRY 3.7B
P/E—5.1816.41
P/B0.571.280.95
Dividend yield—1.78%0.91%
Return on equity−41.13%26.59%0.48%
Free float73.12%49.04%35.90%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the TRILC vs TUPRS Comparison

Price, market cap, valuation multiples, profitability and leverage of TRILC (Türk İlaç Serum) and TUPRS (Tüpraş) side by side as of Nov 12, 2026, 10:00. Of the 15 metrics compared, TRILC leads in 3 and TUPRS leads in 12.

Highlights: Daily change: TUPRS leads (1.58% vs −1.27%). Market cap: TUPRS leads (TRY 682.1B vs TRY 808.9M). P/B: TRILC leads (0.57 vs 1.28). EV/EBITDA: TUPRS leads (2.81 vs 3.96). EV/Sales: TUPRS leads (0.40 vs 1.42). Gross margin: TRILC leads (32.92% vs 15.56%). EBITDA margin (annual): TRILC leads (27.78% vs 13.68%). Net margin (annual): TUPRS leads (10.56% vs −15.17%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs 5.18); by P/B, TRILC trades at the lower multiple (0.57 vs 1.28).

Annual net margin is −15.17% for TRILC and 10.56% for TUPRS; return on equity is −41.13% for TRILC and 26.59% for TUPRS.

The leverage ratio is 83.21 for TRILC and 45.39 for TUPRS; net debt/EBITDA is 3.34 for TRILC and −1.22 for TUPRS. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.